Loading research and source information…
Condition research
Explore selected type 2 diabetes studies of blood sugar control and cardiovascular risk. Some studies require specific background treatment or other health conditions.
MeSH D003924 · Also indexed as Diabetes Mellitus, Type 2
13 covered studies · 7 enrolling · 2 with posted results
Coverage grows through automated registry checks for relevant drug and biological treatment studies. This is not every trial or available treatment, and source checks do not establish clinical benefit. Enrollment and results counts exclude records whose source checks are overdue or under review. Listed ages are only part of eligibility; the study team must confirm eligibility and availability at your location.
Showing 1–8 of 13 matching studies · Page 1 of 2
Sorted by the registry’s latest update, not our check date. With the enrolling filter, locations must be marked recruiting; other views include sites that may be closed.
US: FDA approval not reviewed here
The registry reports completed. This is trial metadata, not an assessment of treatment benefit.
Phase 2 · Completed
Registry enrollment: 210 participants
Study ages: 18 Years to 70 Years
No results-posting date in this record
Read trial record and resultsChecked Oct 27, 2026
US: FDA approval not reviewed here
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Phase 3 · Enrolling participants
Planned enrollment: 1,200 participants
Study ages: 18 Years and older
Recruiting sites listed in: Argentina, Australia, Bulgaria, Canada, China and 9 more countries/territories (see details)
No results-posting date in this record
Read trial record and resultsChecked Oct 27, 2026
The registry reports completed. This is trial metadata, not an assessment of treatment benefit.
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
US: FDA approval not reviewed here
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Phase 2 · Enrolling participants
Planned enrollment: 60 participants
Study ages: 18 Years to 75 Years
Recruiting sites listed in: United States
No results-posting date in this record
Read trial record and resultsChecked Oct 27, 2026
US: FDA approval not reviewed here
The registry reports completed. This is trial metadata, not an assessment of treatment benefit.
Phase 3 · Completed
Registry enrollment: 1,024 participants
Study ages: 18 Years and older
No results-posting date in this record
Read trial record and resultsChecked Oct 28, 2026
US: FDA approval not reviewed here
The registry reports completed. This is trial metadata, not an assessment of treatment benefit.
Phase 3 · Completed
Registry enrollment: 1,023 participants
Study ages: 18 Years and older
No results-posting date in this record
Read trial record and resultsChecked Oct 28, 2026
US: FDA approval not reviewed here
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 3 · Enrolling participants
Planned enrollment: 80 participants
Study ages: 10 Years to 18 Years
Recruiting sites listed in: Argentina, Brazil, Israel, Malaysia, Thailand and 1 more countries/territories (see details)
No results-posting date in this record
Read trial record and resultsChecked Oct 28, 2026
US: FDA approval not reviewed here
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 2 · Enrolling participants
Planned enrollment: 180 participants
Study ages: 18 Years to 75 Years
Recruiting sites listed in: United States
No results-posting date in this record
Read trial record and resultsChecked Oct 28, 2026
US: FDA approval not reviewed here
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 3 · Enrolling participants
Planned enrollment: 170 participants
Study ages: 10 Years to 17 Years
Recruiting sites listed in: Japan, United States
No results-posting date in this record
Read trial record and resultsChecked Oct 28, 2026
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
The registry reports completed. This is trial metadata, not an assessment of treatment benefit.
The registry reports completed. This is trial metadata, not an assessment of treatment benefit.
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.